Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMMUNOSEP trial
2020-005768-74Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Feb 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anakinra and interferon gamma-1b in sepsis (2 arms), sponsored by Hellenic Institute for the Study of Sepsis. Primary endpoint: Mean total SOFA score through day 9. Started Feb 2021; status: completed.
02
Drugs
anakinrainterferon gamma-1b
03
Conditions
sepsis
Beyond the preview
Go deeper on 2020-005768-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005768-74.